Solstice Health Unveils AI Platform to Accelerate the Content Supply Chain for Biopharma Marketing Teams
Company raises $3.5 million to accelerate innovation in biopharma marketing
NEW YORK, Feb. 5, 2025 /PRNewswire/ — Solstice Health, a life sciences marketing engine designed to bridge the gap between innovative marketing and regulatory compliance, today announced the launch of its groundbreaking platform to streamline the way biopharma marketing companies manage the content supply chain, particularly the medical-legal-regulatory (MLR) review process.
Solstice uses advanced generative AI to streamline regulatory compliance and accelerate content distribution. Despite the biopharma industry’s $40 billion annual spend on advertising, many therapeutic launches are struck relying on outdated and generic strategies. Solstice is purpose-built to solve the common pain point of the time-consuming and expensive MLR process.
“Solstice is transforming the medical-legal-regulatory review process with its AI engine.” said Elaine Kang, Director of Marketing at SpringWorks Therapeutics. “By flagging risks early, and ensuring first-pass approval readiness, Solstice enables marketers and review teams to focus on high-impact, strategic decisions rather than manual checks. I’m proud to be part of this journey with the team as they redefine how compliance and speed to market can go hand in hand.”
Solstice has developed the industry’s first AI-powered MLR assistant. The platform leverages secure, responsive AI models to assist in the regulatory review process, enabling marketing and compliance teams to get their products to market faster while ensuring full compliance with regulatory rules.
Solstice’s platform is designed to integrate seamlessly into existing content creation workflows, allowing teams to evaluate content compliance within minutes instead of days or weeks, reducing evaluation cycle timelines by 74%.
“The MLR review process is the biggest choke point in the content supply chain for life science companies,” remarks Ryan Slipakoff, who experienced the pain point acutely as Chief Transformation Officer at Klick Health. “Solving for the time, throughput and cycle reduction of the current system requires an in-depth understanding of needs and operating realities of all users, including agencies, marketers and reviewers. Solstice’s platform is built based on a clear and strong foundation of actual users and operators, offering innovation based on the practical reality of how users will need to use the platform.”
Solstice has raised $3.5 million in seed funding from investors including Twelve Below and Virtue.
About Solstice
Solstice is a life sciences marketing engine designed to accelerate content review cycles for biopharma companies. For more information, visit https://www.solsticehealth.co/.
Media Contact
press@solsticehealth.co
View original content:https://www.prnewswire.com/news-releases/solstice-health-unveils-ai-platform-to-accelerate-the-content-supply-chain-for-biopharma-marketing-teams-302368644.html
SOURCE Solstice Health
